A MAJOR breakthrough in testing for COVID-19 has been made by a US diagnostics company, which will speed up the process of identifying those infected with the deadly virus.
The new test has been developed by the molecular diagnostics company Cepheid and should be rolled out by the beginning of this week. It will allow hospitals and clinics to carry out tests and confirm diagnosis of infection on-site , without the need to send samples to a dedicated diagnostics laboratory. The molecular based test allows for a high degree of accuracy and uses the company’s GeneXpert machine to produce results on-site.
The new test has been developed by the molecular diagnostics company Cepheid and should be rolled out by the beginning of this week. It will allow hospitals and clinics to carry out tests and confirm diagnosis of infection on-site , without the need to send samples to a dedicated diagnostics laboratory. The molecular based test allows for a high degree of accuracy and uses the company’s GeneXpert machine to produce results on-site.
0 Comments